Tumor-derived exosomes are gaining recognition as a promising cancer vaccine for immunotherapies due to their abundant tumor antigens and their role as endogenous carriers for antigen delivery. However, challenges including unstable membrane structures and compromised protein integrity during long-term storage, as well as the absence of effective delivery methods, restrict their clinical applications. Herein, we introduce an exosomes-loaded sugar microneedle (EXO-SMN) patch that not only allows for the long-term storage of exosomes but also facilitates intradermal delivery to enhance immunotherapies. By employing a two-casting micro-molding method, the EXO-SMN patch is composed of an array of tips simply made from trehalose, with a polyvinylpyrrolidone backing. The EXO-SMN patch demonstrates the capability to effectively protect the loaded exosomes, maintaining their membrane structure and protein integrity even after being stored at room temperature for at least one month. Additionally, the EXO-SMN patch possesses strong mechanical properties for skin penetration, facilitating the rapid release of exosomes into the skin within 120 s, and prolonging exosome retention in both skin and lymph nodes compared to intravenous (IV) or subcutaneous (SC) injections. Intradermal vaccination of tumor-derived exosomes via the EXO-SMN patch elicited higher antigen-specific immune responses and resulted in slower tumor growth compared to IV or SC injection. Given its easy to use and reliability, the proposed EXO-SMN patch could eventually facilitate the storage and delivery of exosomes in various biomedical applications.
Read full abstract